GlaxoSmithKline R&D reorganization triggers layoffs at Stevenage -- and Upper Providence
GSK’s new R&D chief Hal Barron has made no secret of the fact that he has a keen interest in refocusing the R&D group …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.